pentamidine has been researched along with Brain Disorders in 2 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumas, M | 1 |
| Bouteille, B | 1 |
| O'Farrell, N | 1 |
| Bradbeer, C | 1 |
| Fitt, S | 1 |
| Welch, JM | 1 |
| Bateman, NT | 1 |
2 other studies available for pentamidine and Brain Disorders
| Article | Year |
|---|---|
[Current status of trypanosomiasis].
Topics: Africa; Animals; Autoantibodies; Blood-Brain Barrier; Brain Diseases; Follow-Up Studies; Forecasting | 1997 |
Cerebral toxoplasmosis and co-trimoxazole prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Humans; Pentamidine; Retrospective Studies; Toxo | 1991 |